HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Ye Selected Research

isovaleric Acidemia

8/2008[Diagnosis of inborn errors of metabolism using tandem mass spectrometry and gas chromatography mass spectrometry].
7/2008[Clinical and mutational study of a Chinese infant with isovaleric acidemia].
5/2005[Application of tandem mass spectrometry in diagnosis of organic acidemias].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Ye Research Topics

Disease

69Neoplasms (Cancer)
04/2022 - 01/2005
15Neoplasm Metastasis (Metastasis)
05/2022 - 12/2007
15Phenylketonurias (Phenylketonuria)
07/2019 - 02/2002
14Inflammation (Inflammations)
01/2022 - 12/2003
14Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 09/2010
13Methylmalonic acidemia
11/2021 - 06/2004
12Chronic Hepatitis B
09/2019 - 07/2003
10Fibrosis (Cirrhosis)
10/2019 - 11/2003
9Stomach Neoplasms (Stomach Cancer)
03/2020 - 05/2013
7Infections
01/2021 - 04/2012
7Metabolic Diseases (Metabolic Disease)
01/2021 - 06/2004
7Liver Cirrhosis (Hepatic Cirrhosis)
03/2018 - 07/2003
6Colonic Neoplasms (Colon Cancer)
04/2022 - 12/2014
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 06/2013
5Glioma (Gliomas)
07/2021 - 01/2019
5Adenocarcinoma
02/2021 - 08/2015
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2016
5Gaucher Disease (Gaucher's Disease)
11/2018 - 11/2012
56-pyruvoyl-tetrahydropterin synthase deficiency
09/2013 - 02/2002
4Carcinogenesis
04/2022 - 01/2005
4Type 2 Diabetes Mellitus (MODY)
04/2022 - 03/2019
4Homocystinuria
10/2021 - 06/2004
4Body Weight (Weight, Body)
01/2021 - 12/2014
4Medium chain acyl CoA dehydrogenase deficiency
01/2021 - 06/2004
4Ovarian Neoplasms (Ovarian Cancer)
02/2020 - 10/2012
4Liver Diseases (Liver Disease)
11/2019 - 12/2003
4Multiple Acyl Coenzyme A Dehydrogenase Deficiency
03/2015 - 05/2005
4Tyrosinemias (Tyrosinemia)
12/2012 - 06/2004
4Propionic Acidemia
08/2008 - 06/2004
3Non-alcoholic Fatty Liver Disease
05/2022 - 01/2019
3Obesity
05/2022 - 02/2019
3COVID-19
09/2021 - 08/2020
3Triple Negative Breast Neoplasms
07/2021 - 01/2016
3Colitis
01/2021 - 12/2014
3Hepatitis
01/2021 - 11/2004
3Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 12/2010
3Hyperthermia
01/2018 - 06/2013
3Carcinoma (Carcinomatosis)
07/2015 - 01/2005
3Vomiting
09/2014 - 07/2008
3VLCAD deficiency
05/2014 - 12/2007
3Hypoglycemia (Reactive Hypoglycemia)
05/2014 - 06/2009
3Niemann-Pick Diseases (Niemann Pick Disease)
02/2014 - 11/2012
3Mucopolysaccharidoses
06/2013 - 04/2009
3Mucopolysaccharidosis IV (Morquio Syndrome)
06/2013 - 07/2012
3Maple Syrup Urine Disease
01/2013 - 08/2008
3isovaleric Acidemia
08/2008 - 05/2005
2Insulin Resistance
05/2022 - 01/2020

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
13Biomarkers (Surrogate Marker)IBA
07/2021 - 11/2003
10Long Noncoding RNAIBA
04/2022 - 12/2014
10AcidsIBA
01/2021 - 06/2004
10EnzymesIBA
02/2019 - 01/2005
9Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 06/2004
8sapropterin (tetrahydrobiopterin)FDA Link
01/2017 - 02/2002
7LipidsIBA
05/2022 - 01/2016
7Biological ProductsIBA
01/2022 - 10/2012
7Pharmaceutical PreparationsIBA
01/2022 - 07/2003
7Messenger RNA (mRNA)IBA
09/2020 - 07/2015
6RNA (Ribonucleic Acid)IBA
01/2022 - 11/2019
6DNA (Deoxyribonucleic Acid)IBA
08/2021 - 06/2004
6CholesterolIBA
02/2021 - 02/2014
6MicroRNAs (MicroRNA)IBA
05/2020 - 01/2013
6CytokinesIBA
07/2019 - 09/2010
5Therapeutic UsesIBA
05/2022 - 05/2005
5Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
11/2021 - 03/2009
5Paclitaxel (Taxol)FDA LinkGeneric
07/2021 - 01/2016
5Small Interfering RNA (siRNA)IBA
11/2019 - 07/2015
5Phenylalanine Hydroxylase (Phenylalanine 4 Monooxygenase)IBA
07/2019 - 05/2005
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 01/2005
4ORALIT (ORS)IBA
06/2022 - 10/2018
4oxidized low density lipoproteinIBA
02/2021 - 01/2016
4Glucose (Dextrose)FDA LinkGeneric
02/2021 - 03/2010
4Amino AcidsFDA Link
10/2020 - 06/2004
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 03/2011
4Matrix Metalloproteinases (MMPs)IBA
01/2020 - 01/2005
4celastrolIBA
01/2016 - 05/2013
4neodymium pyrocatechin disulfonate (NPD)IBA
06/2014 - 11/2012
4Carnitine (L-Carnitine)FDA LinkGeneric
03/2013 - 06/2004
4Capsules (Microcapsules)IBA
05/2005 - 07/2003
3VaccinesIBA
12/2021 - 07/2006
3EmulsionsIBA
07/2021 - 01/2016
3Liposomes (Liposome)IBA
07/2021 - 01/2019
3acylcarnitineIBA
01/2021 - 06/2004
3Insulin (Novolin)FDA Link
01/2021 - 03/2011
3AntioxidantsIBA
01/2021 - 01/2005
3LuciferasesIBA
01/2020 - 06/2004
3BiopterinsIBA
02/2019 - 04/2008
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2019 - 12/2003
3Folic Acid (Vitamin M)FDA LinkGeneric
10/2016 - 04/2008
3InterferonsIBA
02/2016 - 12/2011
3Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA
06/2014 - 01/2013
3Phenylalanine (L-Phenylalanine)FDA Link
12/2012 - 06/2004
3tetrahydropterinIBA
02/2009 - 02/2002
3oxymatrineIBA
11/2004 - 11/2003
3Hyaluronic Acid (Hyaluronan)IBA
11/2004 - 11/2003

Therapy/Procedure

26Therapeutics
04/2022 - 07/2003
6Drug Therapy (Chemotherapy)
07/2021 - 05/2005
4Immunotherapy
01/2021 - 05/2014
4Aftercare (After-Treatment)
01/2018 - 05/2005
3Enzyme Replacement Therapy
11/2012 - 04/2009